The obtained results demonstrated the capability of β-HCH to promote tumor progression through several molecular processes, which include STAT3 canonical and non-canonical activation, endocrine disruption, Aryl Hydrocarbon Receptor activation, and modulation of redox homeostasis and energy metabolism [19,20]. The gene discussed is AHR; the disease is neoplasm.